Erdheim-Chester hastalığı (ECD), çoğunlukla BRAF V600E mutasyonu ile ilişkili, nadir, multisistemik ve idiyopatik bir bozukluktur. Tipik olarak farklı belirtileri nedeniyle geç ve zor tanı konulur. Her ne kadar sessiz bir klinik seyri olsa da ileri evrelerde multipl vital organ tutulumu ile fulminan seyir gösterebilir. Karakteristik radyolojik özellikleri olan, sınıf 2a, non-Langerhans hücreli histiyositozlardandır. Tüm vücut görüntüleme, özellikle iskelet lezyonlarını göstermek için, yararlı olabilir. Her ne kadar görüntülemede tipik yaygın iskelet tutulumu tanıyı öne sürse de kesin tanı için histopatolojik doğrulama gereklidir. Hastalık aynı zamanda kraniyal ya da orbital farklı bulgularla da ortaya çıkabilir.
. A 59-year-old diabetic, hypertensive, hypothyroid female with cardiac pacemaker for complete heart block, was diagnosed with retroperitoneal fibrosis. Tarsorrhaphy was performed for left eye swelling for corneal/visual protection. Subsequently, she developed renal damage along with lower limb swelling. Baseline non-contrast computed tomography (CT) scan revealed diffuse soft tissue mass around the descending aorta and kidneys, resulting in bilateral hydronephrosis. Follow-up CT scan revealed retroperitoneal mass extending up to the posterior mediastinum. PET/CT was performed with intravenous injection of 10 mCi of 
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Peer-review: Externally and internally peer-reviewed. Typically, it manifests with characteristic osteosclerosis of diaphysis and metaphysis with epiphyseal sparing of long bones which can be picked up by bone scintigraphy or CT or PET/CT scan (2). Partial involvement of epiphysis has also been reported in the literature (3). ECD indolently involves various organs or fulminant multisystem failure; central nervous system 40-50%, cardiac 75% (4), pulmonary (43%) or pleural involvement (5) . Retroperitoneal fibrosis and renal involvement are the commonest presentations (6).
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F-FDG PET/CT gained potential importance in early diagnosis of ECD with multisystem involvement enabling whole body acquisition in a single session. Studies have shown excellent specificity of PET scans ranging from 69.2 to 100%; however, sensitivity varies among different organs (range 4.3 to 78.3%) contrary to other imaging modalities (7) . PET/CT provides useful information in appreciation of therapy response earlier, depicting metabolic disease activity. One of the recent studies reported effectiveness of PET/CT in management as 48% of cases (8, 9) .
F-FDG PET scanning depicts metabolic response earlier in neurologic and osseous disease than morphologic changes detected on magnetic resonance imaging (7) . Despite characteristic skeletal findings and multisystem involvement, imaging may help in diagnosis, but histologic evaluation is required for confirmation. Our case presents a rare disease in which multidisciplinary approach and appropriate imaging are essential for timely diagnosis and patient management.
